Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
This study is currently recruiting participants.
Study NCT00073983
Information provided by National Cancer Institute (NCI)
First Received: December 10, 2003
Last Updated: July 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
